Abstract

Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use has been met with many challenges. Portal Instruments Inc. has been developing needle-free medication delivery using a well-designed hand-held device, PRIME, that is safe, intuitive to use, and utilizes advanced electronic control of a focused, high velocity, pressurized liquid injection stream. The PRECISE II human study demonstrated that the PRIME needle-free injection system was safe, well tolerated, and strongly preferred by participants for self-injections over a standard needle and syringe. In addition, the study was able to be completed early for superiority following the success of the pre-defined interim analysis.

Details

Title
Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system
Author
Kelley, E Lynne 1 ; Smith, Richard H 1 ; Corcoran, Gillian 1 ; Nygren, Sandra 1 ; Jacoski, Mary V 1 ; Fernandes, Andrea 1 

 Portal Instruments, Cambridge, MA, USA 
Pages
1915-1922
Publication year
2021
Publication date
Dec 2021
Publisher
Taylor & Francis Ltd.
ISSN
10717544
e-ISSN
15210464
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2691138242
Copyright
© 2021 Portal Instruments Inc. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.